0001840051-22-000001.txt : 20220523 0001840051-22-000001.hdr.sgml : 20220523 20220520211327 ACCESSION NUMBER: 0001840051-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220523 DATE AS OF CHANGE: 20220520 EFFECTIVENESS DATE: 20220523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InflammX Therapeutics, Inc. CENTRAL INDEX KEY: 0001840051 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-446531 FILM NUMBER: 22949414 BUSINESS ADDRESS: STREET 1: 275 BAYSHORE BLVD, UNIT 1607 CITY: TAMPA STATE: FL ZIP: 33606 BUSINESS PHONE: 858-480-2404 MAIL ADDRESS: STREET 1: 275 BAYSHORE BLVD, UNIT 1607 CITY: TAMPA STATE: FL ZIP: 33606 D 1 primary_doc.xml X0708 D LIVE 0001840051 InflammX Therapeutics, Inc. 275 BAYSHORE BLVD, UNIT 1607 TAMPA FL FLORIDA 33606 858-480-2404 DELAWARE None None Corporation true 2020 Brian Levy c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Executive Officer Director David Pool c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Executive Officer James Blair c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director Phil Rosenfeld c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director David Boyer c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director Rajiv Shukla c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director Jason Werner c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director Richard Rubino c/o InflammX Therapeutics, Inc. 275 Bayshore Blvd., Unit 1607 Tampa FL FLORIDA 33606 Director Biotechnology Decline to Disclose 06b false 2022-05-06 false true false 0 Indefinite 0 Indefinite Shares issued as consideration for rights granted to the Issuer under a certain acquisition agreement. false 2 0 0 0 false InflammX Therapeutics, Inc. /s/ David Pool David Pool Chief Financial Officer 2022-05-20